Testing for leukemia in a child typically begins with a simple blood draw and, if results are concerning, moves to a bone marrow sample that confirms the diagnosis. The entire process from first blood test to a confirmed diagnosis usually takes about three days, though some specialized results come back over the following week. Understanding each step can help you know what to expect if your child’s doctor has raised the possibility of leukemia.
Signs That Prompt Testing
Most children aren’t tested for leukemia out of the blue. A doctor typically orders blood work after noticing a pattern of symptoms that doesn’t fit a simpler explanation. The signs that raise suspicion include persistent fatigue and paleness (from low red blood cells), unusual bruising or tiny red dots on the skin called petechiae (from low platelets), and frequent or lingering infections (from abnormal white blood cells). None of these on their own means leukemia, but together they form a picture that warrants a closer look.
During the physical exam, the doctor will feel for swollen lymph nodes in the neck, armpits, or groin, where leukemia cells can collect. They’ll also press gently on your child’s belly to check whether the liver or spleen feels enlarged. Some children complain of bone or joint pain, which happens when abnormal cells crowd the bone marrow. If any of these findings appear alongside abnormal-looking blood work, the next step happens quickly.
The First Test: A Complete Blood Count
A complete blood count, or CBC, is the standard first screening tool. It measures red blood cells, white blood cells, and platelets from a single blood draw. Results are usually available within hours. In a large study of over 200 children diagnosed with the most common form of childhood leukemia (acute lymphoblastic leukemia, or ALL), about 83% had low red blood cell counts at diagnosis, and 83% had low platelet counts. Those two findings together appeared in more than half of all cases.
White blood cell counts can go in either direction. About 37% of children had abnormally high white blood cell counts, while 36% actually had counts that were lower than normal. Roughly a quarter fell in the normal range. This means a “normal” white blood cell number does not rule out leukemia. What matters more is what the cells look like. The CBC includes a differential, which breaks down the types of white blood cells present. If the lab identifies immature cells called blasts circulating in the blood, that’s a strong signal that the bone marrow is producing abnormal cells.
A CBC alone cannot confirm leukemia, but it can strongly suggest it. When the results are concerning, doctors move to the definitive test the same day or the next.
Bone Marrow Aspiration: The Definitive Test
A bone marrow aspiration is the test that actually diagnoses leukemia. A doctor uses a needle to withdraw a small sample of liquid marrow, which is then examined under a microscope. In children, the sample is almost always taken from the back of the hip bone (the posterior iliac crest), because it contains the most marrow, sits far from vital organs, and isn’t a weight-bearing area. For babies younger than 18 months, the front of the shinbone is sometimes used instead.
A formal leukemia diagnosis requires that at least 20% of the cells in the bone marrow sample are immature blast cells. In a healthy child, blasts make up fewer than 5% of marrow cells. When leukemia is present, the number is often far above the 20% threshold.
Sometimes a bone marrow biopsy is done at the same time. While the aspiration pulls out liquid, the biopsy removes a tiny core of solid marrow tissue. This gives pathologists a view of how densely packed the marrow is and whether abnormal cells have replaced normal blood-producing cells.
What Your Child Experiences
Children receive sedation for bone marrow procedures. Procedural sedation is the standard of care in pediatric oncology, and it’s specifically designed to minimize both pain and awareness. An anesthesiologist or specially trained physician administers the sedation, typically through an IV. The medications used produce a deep enough level of sedation that most children have no memory of the procedure afterward. The actual aspiration takes only a few minutes. Your child will be monitored as they wake up, and some soreness at the site is normal for a day or two.
Identifying the Exact Type of Leukemia
Once leukemia is confirmed, additional tests on that same bone marrow sample determine the specific subtype, which directly shapes the treatment plan. These tests run simultaneously, so they don’t require additional procedures.
Flow cytometry is one of the most important. It works by labeling cells with antibodies that attach to specific surface proteins, then passing them through a laser that reads the labels. This tells doctors whether the leukemia involves B-cells, T-cells, or a completely different cell line (myeloid cells). That distinction separates ALL from acute myeloid leukemia (AML) and further subdivides ALL into B-cell or T-cell types. Flow cytometry results on the bone marrow typically come back in about one day.
The full bone marrow biopsy report, which includes the microscopic evaluation of cell appearance and marrow structure, takes closer to four days on average. Altogether, the turnaround time from first bone marrow test to confirmed, subtyped diagnosis averages about three days.
Genetic Testing for Prognosis
Leukemia cells carry specific chromosomal changes that predict how well a child will respond to treatment. Two main techniques identify these changes.
Standard chromosomal analysis (karyotyping) involves growing the leukemia cells in a lab and examining their chromosomes under a microscope. This can reveal whether cells have too many chromosomes (hyperdiploidy, which is generally favorable) or too few (hypodiploidy, which carries a higher risk). It also detects large-scale rearrangements where pieces of one chromosome swap places with another.
However, some critical rearrangements are too subtle to see with standard karyotyping. A technique called FISH (fluorescence in situ hybridization) uses fluorescent probes that bind to specific genes, making even hidden translocations visible. For example, a rearrangement between chromosomes 12 and 21 is one of the most common findings in childhood ALL and carries a favorable prognosis, but it’s essentially invisible without FISH. On the other hand, a translocation between chromosomes 9 and 22 (the “Philadelphia chromosome”) signals a more aggressive form that requires a modified treatment approach. These genetic results can take a week or longer but don’t delay the start of treatment, which typically begins as soon as the basic diagnosis is confirmed.
Chest X-Ray and Imaging
A chest X-ray is routinely performed at diagnosis, primarily to check for a mass in the center of the chest. T-cell ALL in particular can cause a large mass in the area behind the breastbone, which can press on the windpipe or major blood vessels. Identifying this mass before any procedures is critical because it affects how safely a child can be sedated. Children with a mediastinal mass are significantly more likely to need intensive monitoring: in one study, about 45% required ICU admission and 24% needed respiratory support, compared to 8% and 4% of children without a mass.
The X-ray also checks for fluid buildup around the lungs and any signs of heart enlargement. Additional imaging like CT scans or ultrasounds may follow depending on what the initial evaluation reveals, but a chest X-ray is nearly universal.
Spinal Fluid Testing
A lumbar puncture (spinal tap) is performed at diagnosis to check whether leukemia cells have reached the central nervous system. A small amount of spinal fluid is collected and examined under a microscope and, increasingly, with flow cytometry for greater sensitivity. The results place your child into one of several categories. CNS1 means no leukemia cells were found in the spinal fluid. CNS2 means a small number of abnormal cells were detected. CNS3 means clear central nervous system involvement, with a higher cell count and sometimes symptoms like cranial nerve problems or imaging findings.
This classification directly influences treatment intensity. Children with CNS involvement receive additional targeted therapy to clear those cells. The lumbar puncture is typically performed under the same sedation as the bone marrow aspiration, so your child undergoes both at once rather than facing two separate procedures.
How the Timeline Comes Together
For most families, the process moves fast. A concerning CBC result in the morning can lead to a bone marrow aspiration the same day or the next. Flow cytometry results confirming the leukemia type arrive within roughly 24 hours. The full pathology report follows within about four days. Genetic and chromosomal results trickle in over the following one to two weeks, but treatment almost always begins within the first few days of diagnosis, before every last test result is back. The initial blood counts and bone marrow findings provide enough information to start safely, and the treatment plan is refined as genetic details arrive.